Recent content by Billy_Shears

Yes, of course, but not without Apollo 1. It happens.

I would highly advise you to take your vitamin D3 5000 iu even if it (and I doubt) increases tinnitus. D3 is a great immunity booster from everything out there.

Good point. There is a signal, meaning it works, yet, it is still unclear to understand what it is we are missing with FX-322. I guess one could say that the cochlea is the 'final frontier' of medicine. It's a difficult journey to the answer, but a step forward has been made. There is now hope...

47% had statistically significant improvement after seven months of FX-322 treatment. Not bad!

FX-322 is not getting a fair trial and FREQ knows it.

If you're speaking of both ears being the price to pay, then the self-chosen sounds of silence would wreak one into eventual severe depression with no recourse.

There are millions of people who have sensorineural hearing loss around the world who are holding out their only hope for Frequency Therapeutics to find a breakthrough on a signal that FX-322 has already provided. It is a painfully long process in between clinical trials and data readouts - in...

Frequency Therapeutics is a good, sound company with strong management and expertise in the field of progenitor cellular science that happens to have credence in restoring sensorineural hearing loss one day. Restoring hearing loss is like the final frontier of potential medical breakthroughs and...

It appears there is an ongoing lawsuit from a group of investors against Frequency Therapeutics. The investigation concerns whether Frequency Therapeutics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You may have misunderstood me pertaining to audiologists. There is currently an unknown reason for the bias that occurred in Phase 2a. As well, it's well known that any success with FX-322 could effect the hearing aid industry in a negative way - and audiologists are basically the middle-man in...

The science behind PCA is groundbreaking medical technology and FX-322 has been proven to increase audibility and clarity in trail participants with mild-moderate sensorineural hearing loss. In regard to Phase 2a, there was a bias within the trial design and it wouldn't surprise me if not the...

90 days may be enough time to develop hearing function within the womb prior to birth, but out here in the world to regenerate hearing in an adult without a doubt takes a little longer - it is complex but we are getting there. Wait for the full readout, I am very confident there will be good...

Frequency Therapeutics will eventually zero in on successfully treating sensorineural hearing loss, it is only a matter of time. It is back to the drawing board to unlock the answers we need, the signal is there.

A clever manipulative move from insiders, seems like they sell every week to entice speculative buyers leading up to the 90-day. Great for swing traders and those with sensorineural hearing loss - no need to FREQ out, it's good news!

Looking forward to Phase 5... in my ENT Physician's office, both ears!